1. P545 Calprotectin at week 12 is a predictor for histological remission in ulcerative colitis patients treated with Vedolizumab. (27th May 2021) Authors: Rubstov, D; Kakkadasam Ramaswamy, P; Edwards, J; Shukla, D; Willmann, L; Moattar, H; Bhullar, M; Ishaq, N; Dorrington, A; Mohsen, W Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗